CLARK IAN T bought CRVS
June 11, 2026 · Form 4 insider transaction
CLARK IAN T bought 15,000 shares of Corvus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$0.00
Total value
N/A
InsiderCLARK IAN T
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 15, 2026
Shares owned after15,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.